Publications by authors named "Crystal Parker"

Objective: The objective of this study was to evaluate the impact of premedications given as an adjunct to carboplatin on the incidence of hypersensitivity reactions in women with ovarian cancer. Medications of interest include a histamine1 (H1 ) and histamine2 (H2 ) blocker in addition to dexamethasone.

Methods: This was a retrospective chart review evaluating the addition of an H1 and H2 blocker in addition to dexamethasone as standard premedications on the incidence of carboplatin hypersensitivity reactions (CHRs) in women with ovarian cancer.

View Article and Find Full Text PDF

Background: Food allergies affect 2.5% of the US population. Results of studies show that minorities have the highest prevalence of food allergies.

View Article and Find Full Text PDF

Background: Increasingly, teachers are the first respondents to food allergic reactions in schools. Studies of food allergy in school settings have identified deficiencies in teacher recognition and treatment of reactions. We sought to determine the effect of a didactic session on teacher knowledge of the causative foods, symptoms, and treatment of reactions in diverse elementary schools.

View Article and Find Full Text PDF

We examined how chaplains respond to grief and determined the prevalence of disenfranchised grief (i.e., grief that is not or cannot be acknowledged or supported by society) in healthcare chaplains.

View Article and Find Full Text PDF

There is a paucity of data regarding prevalence and characteristics of adult seafood allergy in United States cohorts. This study was designed to determine the characteristics of patient-reported seafood allergy in a large allergy referral adult population. Retrospective analysis was performed of laboratory and clinical characteristics of seafood-allergic patients in three allergy clinics in the Texas Medical Center between January 1, 1997 and January 30, 2010.

View Article and Find Full Text PDF

Background: Radiotherapy is the current standard of care for patients with localized squamous cell cancer of the anal canal. The goal of the current study was to evaluate long-term quality of life (QoL) in patients after this treatment.

Methods: Questionnaires were mailed to 80 patients treated with definitive radiotherapy, with or without concurrent chemotherapy, for anal cancer, with a minimum 2-year interval after the completion of radiotherapy.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined whether a more intense chemotherapy protocol (HIT-GBM-C) could improve survival rates for pediatric patients with high-grade glioma (HGG) and diffuse intrinsic pontine glioma (DIPG).
  • Pediatric patients received standard radiation alongside a combination of chemotherapies, including cisplatin, etoposide, and vincristine, followed by additional cycles of chemotherapy and oral valproic acid.
  • Results showed that while overall survival rates did not significantly benefit patients with residual tumors, those who had complete tumor resection demonstrated a significantly higher 5-year survival rate (63%) compared to historical controls (17%).
View Article and Find Full Text PDF

Objective: Pegylated liposomal doxorubicin (PLD) was introduced to reduce the adverse effect of doxorubicin in treating recurrent ovarian cancer. We sought to characterize the efficacy and adverse-effect profile of PLD in different doses and to evaluate predictive factors of palmar-plantar erythrodysesthesia (PPE).

Methods: Patients with recurrent ovarian, primary peritoneal, and fallopian tube carcinoma treated with single-agent PLD between 1996 and 2006 at The University of Texas M.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess whether higher magnesium supplementation during hydration can prevent chemotherapy-induced hypomagnesemia (CIH) in cervical cancer patients receiving cisplatin and radiation.
  • Initially, magnesium was increased from 1 g to 2 g, but CIH still occurred in 32.6% of patients; thus, further increase to 3 g led to a significant decrease in CIH episodes.
  • The results showed a 49.6% reduction in CIH instances in the second intervention group and a complete absence of persistent CIH, suggesting that higher magnesium doses significantly help in managing this side effect of treatment.
View Article and Find Full Text PDF